Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Govt Bans Export of...

    Govt Bans Export of Paracetemol, vitamins, and other key drugs, details

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2020-03-04T11:38:50+05:30  |  Updated On 4 March 2020 11:38 AM IST
    Govt Bans Export of Paracetemol, vitamins, and other key drugs, details

    The ban comes into force immediately and will continue till further orders

    New Delhi: Wih cases of coronavirus being reported from various parts of the country, the Government has made amendments in the export policy and restricted export of specified APIs (Active Pharmaceutical Ingredients) and formulations made from these APIs.

    A notification issued by Directorate General of Foreign Trade, M/o Commerce and Industry says that the restrictions will come into immediate effect and until further orders. The notification covers the following APIs and formulations made from these APIs:

    • Paracetamol,
    • Tinidazole,
    • Metronidazole,
    • Acyclovir,
    • Vitamin B1,
    • Vitamin B6,
    • Vitamin B12,
    • Progesterone,
    • Chloramphenicol,
    • Erythromycin Salts,
    • Neomycin,
    • Clindamycin Salts,
    • Ornidazole

    It is widely known India is heavily dependent on China for import of key APIs and KSM and because of the wake of COVID-19, it has created a concern that the supplies of Active Pharmaceutical Ingredients (APIs) / Key Starting Materials (KSM) from China might be disrupted, resulting in a shortage of medicines in the country.

    The rise of Coronavirus has raised concerns on the availability of API's and API's formulations.

    Medical Dialogues has earlier reported that in the light of coronavirus outbreak worldwide, the apex drug regulator National Pharmaceutical Pricing Authority (NPPA) had identified 58 significant APIs for monitoring of their availability to prevent any shortage of drugs in India and to take preventive measures over illegal hoarding and black-marketing in the country.

    For the same Rajesh K. Agrawal, Director (M&E), had directed all importers of APIs/manufacturers of formulations and APIs/ stockists to submit information about these drugs in the prescribed format.

    Read also: Covid-19 Impact: NPPA Asks Drugmakers To Submit Availablility Data Of 58 APIs, Details

    Recently, Indian drugmaker Sun Pharmaceutical Industries Ltd reported a shortage of its generic version of hypertension drug pindolol, due to a lack of pharmaceutical ingredients while stressing the shortfall does not stem from China.

    "At the moment, we haven't seen any major disruption in API supplies due to the coronavirus outbreak in China," Sun Pharma reiterated, without giving details on the reasons for the shortfall in pindolol ingredients.

    Read Also: Shortage of generic version of BP drug pindolol, says Sun Pharma

    apiactive-pharmaceutical-ingredientcoronaviruscovid-19ministry-of-commerce-and-industryParacetamol

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok